S&P 500   3,119.11 (+0.20%)
DOW   27,695.58 (+0.17%)
QQQ   202.86 (+0.21%)
AAPL   265.56 (+1.46%)
FB   199.43 (+0.36%)
MSFT   150.00 (+0.10%)
GOOGL   1,324.36 (+0.41%)
AMZN   1,744.11 (-0.94%)
NVDA   208.70 (-0.34%)
MU   46.54 (+0.50%)
BABA   200.80 (+3.64%)
GE   10.79 (-1.10%)
TSLA   330.41 (-0.79%)
T   38.21 (+0.29%)
AMD   39.64 (-0.13%)
F   8.93 (-0.22%)
PRI   134.52 (+1.00%)
NFLX   303.28 (-0.34%)
GILD   66.17 (-0.87%)
DIS   147.73 (-0.37%)
S&P 500   3,119.11 (+0.20%)
DOW   27,695.58 (+0.17%)
QQQ   202.86 (+0.21%)
AAPL   265.56 (+1.46%)
FB   199.43 (+0.36%)
MSFT   150.00 (+0.10%)
GOOGL   1,324.36 (+0.41%)
AMZN   1,744.11 (-0.94%)
NVDA   208.70 (-0.34%)
MU   46.54 (+0.50%)
BABA   200.80 (+3.64%)
GE   10.79 (-1.10%)
TSLA   330.41 (-0.79%)
T   38.21 (+0.29%)
AMD   39.64 (-0.13%)
F   8.93 (-0.22%)
PRI   134.52 (+1.00%)
NFLX   303.28 (-0.34%)
GILD   66.17 (-0.87%)
DIS   147.73 (-0.37%)
S&P 500   3,119.11 (+0.20%)
DOW   27,695.58 (+0.17%)
QQQ   202.86 (+0.21%)
AAPL   265.56 (+1.46%)
FB   199.43 (+0.36%)
MSFT   150.00 (+0.10%)
GOOGL   1,324.36 (+0.41%)
AMZN   1,744.11 (-0.94%)
NVDA   208.70 (-0.34%)
MU   46.54 (+0.50%)
BABA   200.80 (+3.64%)
GE   10.79 (-1.10%)
TSLA   330.41 (-0.79%)
T   38.21 (+0.29%)
AMD   39.64 (-0.13%)
F   8.93 (-0.22%)
PRI   134.52 (+1.00%)
NFLX   303.28 (-0.34%)
GILD   66.17 (-0.87%)
DIS   147.73 (-0.37%)
S&P 500   3,119.11 (+0.20%)
DOW   27,695.58 (+0.17%)
QQQ   202.86 (+0.21%)
AAPL   265.56 (+1.46%)
FB   199.43 (+0.36%)
MSFT   150.00 (+0.10%)
GOOGL   1,324.36 (+0.41%)
AMZN   1,744.11 (-0.94%)
NVDA   208.70 (-0.34%)
MU   46.54 (+0.50%)
BABA   200.80 (+3.64%)
GE   10.79 (-1.10%)
TSLA   330.41 (-0.79%)
T   38.21 (+0.29%)
AMD   39.64 (-0.13%)
F   8.93 (-0.22%)
PRI   134.52 (+1.00%)
NFLX   303.28 (-0.34%)
GILD   66.17 (-0.87%)
DIS   147.73 (-0.37%)
Log in

NYSEARCA:IDNA - iShares Genomics Immunology and Healthcare ETF Stock Price, Forecast & News

$29.40
-0.22 (-0.74 %)
(As of 12/5/2019 03:43 PM ET)
Add
Today's Range
$29.40
Now: $29.40▼
$29.78
50-Day Range
$24.47
MA: $26.78▼
$29.64
52-Week Range
$23.62
Now: $29.40▼
$29.64
Volume3,804 shs
Average Volume2,532 shs
Market Capitalization$26.46 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Basic Details

Issuer iShares
Fund NameiShares Genomics Immunology and Healthcare ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IDNA
Inception Date6/11/2019
Fund ManagerRachel Aguirre, Jennifer Hsui, Alan Mason, Greg Savage, Amy Whitelaw
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$26.39 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker
AMEX:IDNA Rates by TradingView

Receive IDNA News and Ratings via Email

Sign-up to receive the latest news and ratings for IDNA and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)
Currency Exposure of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)
Sector Exposure of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)
Industry Exposure of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Frequently Asked Questions

What is iShares Genomics Immunology and Healthcare ETF's stock symbol?

iShares Genomics Immunology and Healthcare ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IDNA."

Has iShares Genomics Immunology and Healthcare ETF been receiving favorable news coverage?

Media stories about IDNA stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. iShares Genomics Immunology and Healthcare ETF earned a news sentiment score of 0.7 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for iShares Genomics Immunology and Healthcare ETF.

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is iShares Genomics Immunology and Healthcare ETF's stock price today?

One share of IDNA stock can currently be purchased for approximately $29.40.

How big of a company is iShares Genomics Immunology and Healthcare ETF?

iShares Genomics Immunology and Healthcare ETF has a market capitalization of $26.46 million. View Additional Information About iShares Genomics Immunology and Healthcare ETF.


MarketBeat Community Rating for iShares Genomics Immunology and Healthcare ETF (NYSEARCA IDNA)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  8
MarketBeat's community ratings are surveys of what our community members think about iShares Genomics Immunology and Healthcare ETF and other stocks. Vote "Outperform" if you believe IDNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Featured Article: Why are gap-down stocks important?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel